September 7, 2011 Summary: Our September focus is on National Atrial Fibrillation Awareness Month, including US Senate passage of the Atrial Fibrillation Resolution and current afib awareness public service announcements. Reading time: 1–2 minutes By Mellanie True Hills September 7, 2011 Dallas, TX — In our September Patient Perspective column in EP Lab Digest, we …
Read More
By Jennifer L.W. Fink Summary: The drug rivaroxaban was shown to be as good as warfarin for stroke prevention in a large study that was recently published in the New England Journal of Medicine. Approximate reading time: 3–5 minutes September 6, 2011 A New England Journal of Medicine article, Rivaroxaban versus Warfarin in Nonvalvular Atrial …
Read More
September 1, 2011 Summary: A new Atrial Fibrillation in Primary Care (AFIP) Tool can be useful for patients in working with their doctors, especially those with newly-diagnosed atrial fibrillation. Two of the coauthors, Professors John Camm and Gregory Lip, are members of the StopAfib.org Global Medical Advisory Board, and StopAfib.org founder Mellanie True Hills provided …
Read More
In honor of Atrial Fibrillation (Afib) Awareness Month, Team AFib, of which StopAfib.org is a member, would like to invite you to our second webinar, “AFib CARE: Creating A Role for Effective Teams”, taking place at 1:00 p.m. ET on Wednesday, September 14. During the live webinar, a host of expert panelists will provide guidance …
Read More
August 15, 2011 Summary: We explore the concern of the atrial fibrillation patient community as to whether staying in afib long term could be a "death sentence" in the Patient Perspective column in the August issue of EP Lab Digest. Reading time: 1–2 minutes Dallas, TX — In her first regular Patient Perspective column, which …
Read More
August 10, 2011 Summary: StopAfib.org applauds US Senate passage by unanimous consent of the Atrial Fibrillation Resolution (S. Res. 243) to promote atrial fibrillation awareness, diagnosis, and treatment Reading time: 1–2 minutes Great news! The US Senate has passed the Atrial Fibrillation Resolution (S. Res. 243) by unanimous consent. The resolution, introduced by Sen. Michael …
Read More
By Mellanie True Hills and Peggy Noonan Summary: In light of recent news about the use of Multaq (dronedarone) for atrial fibrillation, it's time to put into context for patients what has transpired in the two years since FDA approval. Aproximate reading time: 15–20 minutes August 9, 2011 It has been two years since the …
Read More
By Mellanie True Hills and Peggy Noonan Summary: As StopAfib.org explores the controversy surrounding Multaq (dronedarone), we see what some experts have said to help patients put this information into context Aproximate reading time: 5–7 minutes August 9, 2011 As we reported in our companion piece on Multaq, What Do We Know About Multaq (dronedarone) …
Read More
By Mellanie True Hills July 7, 2011 Summary: An FDA Advisory Committee will review rivaroxaban (Xarelto) as an alternative to warfarin for stroke prevention in atrial fibrillation on September 8, 2011. In this video interview, Dr. Elaine Hylek discusses the results of clinical trials of rivaroxaban and the currently-approved dabigatran (Pradaxa). Reading and watching time: …
Read More
June 28, 2011 Summary: Here is the transcript of our June 13 afib community chat with the atrial fibrillation experts at the Cleveland Clinic, which provided a rare opportunity to get answers to the most pressing questions of the afib community. There were too many questions to answer during the chat, but the doctors generously …
Read More